Evaxion A (EVAX) Return on Equity [ROE] (2020 - 2026)
Evaxion A (EVAX) recorded Return on Equity [ROE] of -89.12% in Q2 2026, up 55.43 percentage points from -144.55% a year earlier but down 14.84 percentage points from the prior quarter.
Powered by 
Analysis
Evaxion A (EVAX) Return on Equity [ROE] (2020 - 2026) Analysis & Trends
For FY2025, Evaxion A reported Return on Equity [ROE] of -100.18%.
- Annual Return on Equity [ROE] has a five-year change of +82.97 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -1238.11% in FY2023 (-1124.37 pp), -113.74% in FY2022 (-32.29 pp) and -81.45% in FY2021 (+101.69 pp).
- Quarterly Return on Equity [ROE] has ranged from -1727.51% in Q3 2024 to -52.04% in Q4 2025 over the past five years.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 1675.34 percentage points in Q3 2025, against a drop of 249.78 percentage points in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at -74.28% (Q1 2026), -52.04% (Q4 2025) and -52.16% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Evaxion A | 21.02 Mn | -45.23 Mn | - | -89.12% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -89.12% |
| Mar 31, 2026 | -74.28% |
| Dec 31, 2025 | -52.04% |
| Sep 30, 2025 | -52.16% |
| Jun 30, 2025 | -144.55% |
| Mar 31, 2025 | -307.03% |
| Sep 30, 2024 | -1,727.51% |
| Jun 30, 2024 | -788.44% |
| Jun 30, 2023 | -538.66% |
| Mar 31, 2023 | -317.53% |
| Dec 31, 2022 | -268.22% |
| Sep 30, 2022 | -182.81% |
| Jun 30, 2022 | -267.24% |
| Mar 31, 2022 | -185.08% |
| Dec 31, 2021 | -99.95% |
| Sep 30, 2021 | -106.19% |
| Jun 30, 2021 | -77.34% |
| Mar 31, 2021 | -91.93% |
| Dec 31, 2020 | -201.06% |
API Access
Evaxion A Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "EVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();